{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-086476","form_type":"8-K","ticker":"CUE","cik":"0001645460","company_name":"Cue Biopharma, Inc.","filed_at":"2024-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.937388+00:00","generated_at":"2026-05-31T16:18:44.400843+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cue Biopharma restructures, cuts workforce 25%, extends cash runway to mid-2025","bullets":["Reduces workforce by ~25% across R&D and G&A; CEO Daniel Passeri takes 50% salary reduction, execs forgo 2023 bonuses.","Prioritizes autoimmune programs CUE-401 (partnered with Ono) and CUE-501; retains oncology CUE-101/102 Phase 1 data maturation.","Projects FY2025 annual cash burn of ~$30M, an ~25% reduction in operating expenses.","Expects extended cash runway into mid-2025; actively pursuing partnerships for oncology programs.","Restructuring effective July 24, 2024; aims to reduce capital requirements and strengthen operational efficiencies."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-086476","json":"https://secwatch.observer/filing/0000950170-24-086476.json","markdown":"https://secwatch.observer/filing/0000950170-24-086476.md","text":"https://secwatch.observer/filing/0000950170-24-086476.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645460/000095017024086476/0000950170-24-086476-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645460/000095017024086476/cue-20240724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T16:18:44.400843+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}